12.5/1000 322M (Kazano 12.5 mg / 1000 mg)

Generic Name: alogliptin/metformin

Pill imprint 12.5/1000 322M has been identified as Kazano 12.5 mg / 1000 mg.

Kazano is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Kazano 12.5 mg / 1000 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 12.5/1000 322M

Kazano
Generic Name:
alogliptin/metformin
Imprint:
12.5/1000
322M
Strength:
12.5 mg / 1000 mg
Color:
Yellow
Shape:
Rectangle
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Takeda Pharmaceuticals America, Inc.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)